Food & Drug Administration (2025) Ozempic, DailyMed (2025) Wegovy, DailyMed (2024) Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine (2021) Vitamin B12, National Institutes of Health Office of Dietary Supplements (2024) Vitamin B12 injections: What they can and cant do, Cleveland Clinic (2024) Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes, Obesity Pillars (2024) Inverse association between serum vitamin B12 concentration and obesity among adults in the United States, Frontiers in Endocrinology (Lausanne) (2019) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Data compiled by SHOOK Research LLC based on the time period from 6/30/21 - 6/30/22
The medication is primarily approved for type 2 diabetes but is commonly prescribed off-label for long-term weight management, while Phentermine is FDA-approved specifically for short-term weight loss and is typically used for only a few weeks
Full Answer: AOD-9604 completed six human clinical trials involving over 900 participants, and its safety profile was consistently favorable
